Clinical Trial Update: Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of teriflunomide in relapsing multiple sclerosis patients treated with interferon-beta; the study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• AUBAGIO (TERIFLUNOMIDE)
• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis Relapse | Phase 3 | Status: TERMINATED | Results posted: 2014-05-22